Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 1
1994 3
1995 5
1996 7
1997 9
1998 19
1999 48
2000 34
2001 38
2002 44
2003 34
2004 40
2005 36
2006 38
2007 26
2008 34
2009 35
2010 33
2011 48
2012 52
2013 47
2014 46
2015 38
2016 45
2017 47
2018 44
2019 52
2020 42
2021 39
2022 32
2023 3
Text availability
Article attribute
Article type
Publication date

Search Results

916 results
Results by year
Filters applied: . Clear all
Page 1
The pharmacogenetics of type 2 diabetes: a systematic review.
Maruthur NM, Gribble MO, Bennett WL, Bolen S, Wilson LM, Balakrishnan P, Sahu A, Bass E, Kao WH, Clark JM. Maruthur NM, et al. Diabetes Care. 2014;37(3):876-86. doi: 10.2337/dc13-1276. Diabetes Care. 2014. PMID: 24558078 Free PMC article. Review.
RESULTS: Of 7,279 citations, we included 34 articles (N = 10,407) evaluating metformin (n = 14), sulfonylureas (n = 4), repaglinide (n = 8), pioglitazone (n = 3), rosiglitazone (n = 4), and acarbose (n = 4). ...CONCLUSIONS: We found evidence of pharmacogenetic interactions …
RESULTS: Of 7,279 citations, we included 34 articles (N = 10,407) evaluating metformin (n = 14), sulfonylureas (n = 4), repaglinide ( …
Repaglinide.
Balfour JA, Faulds D. Balfour JA, et al. Drugs Aging. 1998 Aug;13(2):173-80. doi: 10.2165/00002512-199813020-00008. Drugs Aging. 1998. PMID: 9739505 Review.
Repaglinide is rapidly absorbed and eliminated, which may allow a relatively fast onset and offset of action. ...Addition of repaglinide to existing metformin therapy resulted in improved glycaemic control. ...
Repaglinide is rapidly absorbed and eliminated, which may allow a relatively fast onset and offset of action. ...Addition of repag
Pharmacogenomics of glinides.
Chen M, Hu C, Jia W. Chen M, et al. Pharmacogenomics. 2015 Jan;16(1):45-60. doi: 10.2217/pgs.14.152. Pharmacogenomics. 2015. PMID: 25560470 Review.
Glinides, including repaglinide, nateglinide and mitiglinide, are a type of fasting insulin secretagogue that could help to mimic early-phase insulin release, thus providing improved control of the postprandial glucose levels. ...
Glinides, including repaglinide, nateglinide and mitiglinide, are a type of fasting insulin secretagogue that could help to mimic ear …
[Repaglinide].
Quast U. Quast U. Dtsch Med Wochenschr. 2001 May 11;126(19):559-60. doi: 10.1055/s-2001-13801. Dtsch Med Wochenschr. 2001. PMID: 11402913 German. No abstract available.
Characteristics of repaglinide effects on insulin secretion.
Takahashi H, Hidaka S, Seki C, Yokoi N, Seino S. Takahashi H, et al. Eur J Pharmacol. 2018 Jun 5;828:52-59. doi: 10.1016/j.ejphar.2018.03.025. Epub 2018 Mar 16. Eur J Pharmacol. 2018. PMID: 29555503
The dynamics of insulin secretion stimulated by repaglinide, a glinide, and the combinatorial effects of repaglinide and incretin were investigated. ...The Ca(2+) dynamics was similar for repaglinide and glimepiride at 8.8 mM glucose. Our data indicate that …
The dynamics of insulin secretion stimulated by repaglinide, a glinide, and the combinatorial effects of repaglinide and incre …
Repaglinide in combination therapy.
Moses R. Moses R. Diabetes Nutr Metab. 2002 Dec;15(6 Suppl):33-8. Diabetes Nutr Metab. 2002. PMID: 12702006 Review.
The combination of repaglinide and metformin resulted in reduced fasting plasma glucose concentrations (by 2.2 mmol/l) and HbA1c (by 1.4%). ...The combination of repaglinide and each TZD also resulted in consistent decreases in fasting plasma glucose concentrations …
The combination of repaglinide and metformin resulted in reduced fasting plasma glucose concentrations (by 2.2 mmol/l) and HbA1c (by …
Quantitation of the new hypoglycaemic agent AG-EE 388 ZW in human plasma by automated high-performance liquid chromatography with electrochemical detection.
Greischel A, Beschke K, Rapp H, Roth W. Greischel A, et al. J Chromatogr. 1991 Jul 17;568(1):246-52. doi: 10.1016/0378-4347(91)80360-o. J Chromatogr. 1991. PMID: 1770103
A sensitive and selective high-performance liquid chromatographic assay has been developed for a new hypoglycaemic agent AG-EE 388 ZW (I) in human plasma. Plasma samples containing I were acidified with 0.2 M hydrochloric acid, directly injected into C …
A sensitive and selective high-performance liquid chromatographic assay has been developed for a new hypoglycaemic agent AG-EE
Repaglinide: a review of its use in type 2 diabetes mellitus.
Scott LJ. Scott LJ. Drugs. 2012 Jan 22;72(2):249-72. doi: 10.2165/11207600-000000000-00000. Drugs. 2012. PMID: 22268393 Review.
Meglitinides, including repaglinide, have a distinct binding site at the beta-cell membrane, which differs from that of sulfonylureas, and corresponds to greater insulinotropic effects with repaglinide than with glibenclamide and/or glimepiride and a more rapid onse …
Meglitinides, including repaglinide, have a distinct binding site at the beta-cell membrane, which differs from that of sulfonylureas …
Repaglinide: a review of its therapeutic use in type 2 diabetes mellitus.
Culy CR, Jarvis B. Culy CR, et al. Drugs. 2001;61(11):1625-60. doi: 10.2165/00003495-200161110-00008. Drugs. 2001. PMID: 11577798 Review.
Patients can vary their meal timetable with repaglinide: the glucose-lowering efficacy of repaglinide was similar for patients consuming 2, 3 or 4 meals a day. ...Unlike glibenclamide, the risk of hypoglycaemia in patients receiving repaglinide was not increa …
Patients can vary their meal timetable with repaglinide: the glucose-lowering efficacy of repaglinide was similar for patients …
Development of anti-acanthamoebic approaches.
Mungroo MR, Tong T, Khan NA, Anuar TS, Maciver SK, Siddiqui R. Mungroo MR, et al. Int Microbiol. 2021 Aug;24(3):363-371. doi: 10.1007/s10123-021-00171-3. Epub 2021 Mar 23. Int Microbiol. 2021. PMID: 33754231
The results indicated that acarbose, indaziflam, terbuthylazine, glimepiride, inositol, vildagliptin and repaglinide showed anti-amoebic effects. Compounds showed minimal toxicity on human cells. ...
The results indicated that acarbose, indaziflam, terbuthylazine, glimepiride, inositol, vildagliptin and repaglinide showed anti-amoe …
916 results